212 related articles for article (PubMed ID: 33675555)
1. N-acylethanolamine-hydrolysing acid amidase: A new potential target to treat paclitaxel-induced neuropathy.
Toma W; Caillaud M; Patel NH; Tran TH; Donvito G; Roberts J; Bagdas D; Jackson A; Lichtman A; Gewirtz DA; Makriyannis A; Malamas MS; Imad Damaj M
Eur J Pain; 2021 Jul; 25(6):1367-1380. PubMed ID: 33675555
[TBL] [Abstract][Full Text] [Related]
2. Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models.
Sasso O; Moreno-Sanz G; Martucci C; Realini N; Dionisi M; Mengatto L; Duranti A; Tarozzo G; Tarzia G; Mor M; Bertorelli R; Reggiani A; Piomelli D
Pain; 2013 Mar; 154(3):350-360. PubMed ID: 23218523
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of cyanamides as potent and selective N-acylethanolamine acid amidase inhibitors.
Malamas MS; Farah SI; Lamani M; Pelekoudas DN; Perry NT; Rajarshi G; Miyabe CY; Chandrashekhar H; West J; Pavlopoulos S; Makriyannis A
Bioorg Med Chem; 2020 Jan; 28(1):115195. PubMed ID: 31761726
[TBL] [Abstract][Full Text] [Related]
4. Antinociceptive Profile of ARN19702, (2-Ethylsulfonylphenyl)-[(2S)-4-(6-fluoro-1,3-benzothiazol-2-yl)-2-methylpiperazin-1-yl]methanone, a Novel Orally Active
Fotio Y; Sasso O; Ciccocioppo R; Piomelli D
J Pharmacol Exp Ther; 2021 Aug; 378(2):70-76. PubMed ID: 33986036
[No Abstract] [Full Text] [Related]
5. Anti-Inflammatory Effects of Fucoxanthinol in LPS-Induced RAW264.7 Cells through the NAAA-PEA Pathway.
Jin W; Yang L; Yi Z; Fang H; Chen W; Hong Z; Zhang Y; Zhang G; Li L
Mar Drugs; 2020 Apr; 18(4):. PubMed ID: 32326173
[TBL] [Abstract][Full Text] [Related]
6. Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation.
Solorzano C; Zhu C; Battista N; Astarita G; Lodola A; Rivara S; Mor M; Russo R; Maccarrone M; Antonietti F; Duranti A; Tontini A; Cuzzocrea S; Tarzia G; Piomelli D
Proc Natl Acad Sci U S A; 2009 Dec; 106(49):20966-71. PubMed ID: 19926854
[TBL] [Abstract][Full Text] [Related]
7. Targeting Peroxisome Proliferator-Activated Receptor-α (PPAR- α) to reduce paclitaxel-induced peripheral neuropathy.
Caillaud M; Patel NH; White A; Wood M; Contreras KM; Toma W; Alkhlaif Y; Roberts JL; Tran TH; Jackson AB; Poklis J; Gewirtz DA; Damaj MI
Brain Behav Immun; 2021 Mar; 93():172-185. PubMed ID: 33434562
[TBL] [Abstract][Full Text] [Related]
8. N-Acylethanolamine acid amidase (NAAA) inhibitor F215 as a novel therapeutic agent for osteoarthritis.
Zhou P; Xiang L; Yang Y; Wu Y; Hu T; Liu X; Lin F; Xiu Y; Wu K; Lu C; Ren J; Qiu Y; Li Y
Pharmacol Res; 2019 Jul; 145():104264. PubMed ID: 31063807
[TBL] [Abstract][Full Text] [Related]
9. Desloratadine ameliorates paclitaxel-induced peripheral neuropathy and hypersensitivity reactions in mice.
Lu J; Zhao XJ; Ruan Y; Liu XJ; Di X; Xu R; Wang JY; Qian MY; Jin HM; Li WJ; Shen X
Acta Pharmacol Sin; 2024 May; ():. PubMed ID: 38789495
[TBL] [Abstract][Full Text] [Related]
10. N-Acylethanolamine acid amidase (NAAA) is dysregulated in colorectal cancer patients and its inhibition reduces experimental cancer growth.
Romano B; Pagano E; Iannotti FA; Piscitelli F; Brancaleone V; Lucariello G; Nanì MF; Fiorino F; Sparaco R; Vanacore G; Di Tella F; Cicia D; Lionetti R; Makriyannis A; Malamas M; De Luca M; Aprea G; D'Armiento M; Capasso R; Sbarro B; Venneri T; Di Marzo V; Borrelli F; Izzo AA
Br J Pharmacol; 2022 Apr; 179(8):1679-1694. PubMed ID: 34791641
[TBL] [Abstract][Full Text] [Related]
11. A Fenofibrate Diet Prevents Paclitaxel-Induced Peripheral Neuropathy in Mice.
Caillaud M; Patel NH; Toma W; White A; Thompson D; Mann J; Tran TH; Roberts JL; Poklis JL; Bigbee JW; Fang X; Gewirtz DA; Damaj MI
Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33383736
[TBL] [Abstract][Full Text] [Related]
12. Potential analgesic effects of a novel N-acylethanolamine acid amidase inhibitor F96 through PPAR-α.
Yang L; Li L; Chen L; Li Y; Chen H; Li Y; Ji G; Lin D; Liu Z; Qiu Y
Sci Rep; 2015 Aug; 5():13565. PubMed ID: 26310614
[TBL] [Abstract][Full Text] [Related]
13. N-acylethanolamine-hydrolyzing acid amidase and fatty acid amide hydrolase inhibition differentially affect N-acylethanolamine levels and macrophage activation.
Alhouayek M; Bottemanne P; Makriyannis A; Muccioli GG
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 May; 1862(5):474-484. PubMed ID: 28065729
[TBL] [Abstract][Full Text] [Related]
14. N-acylethanolamine acid amidase (NAAA) inhibition decreases the motivation for alcohol in Marchigian Sardinian alcohol-preferring rats.
Fotio Y; Ciccocioppo R; Piomelli D
Psychopharmacology (Berl); 2021 Jan; 238(1):249-258. PubMed ID: 33037452
[TBL] [Abstract][Full Text] [Related]
15. N-Acylethanolamine Acid Amidase contributes to disease progression in a mouse model of multiple sclerosis.
Pontis S; Palese F; Summa M; Realini N; Lanfranco M; De Mei C; Piomelli D
Pharmacol Res; 2020 Oct; 160():105064. PubMed ID: 32634582
[TBL] [Abstract][Full Text] [Related]
16. Inflammation-restricted anti-inflammatory activities of a N-acylethanolamine acid amidase (NAAA) inhibitor F215.
Li Y; Zhou P; Chen H; Chen Q; Kuang X; Lu C; Ren J; Qiu Y
Pharmacol Res; 2018 Jun; 132():7-14. PubMed ID: 29572189
[TBL] [Abstract][Full Text] [Related]
17.
Piomelli D; Scalvini L; Fotio Y; Lodola A; Spadoni G; Tarzia G; Mor M
J Med Chem; 2020 Jul; 63(14):7475-7490. PubMed ID: 32191459
[No Abstract] [Full Text] [Related]
18. NAAA inhibitor F96 attenuates BBB disruption and secondary injury after traumatic brain injury (TBI).
Li Y; Zhou P; Hu T; Ren J; Xu Y; Qiu Y; Lu C; Li Y
Eur J Pharmacol; 2021 Dec; 912():174561. PubMed ID: 34655598
[TBL] [Abstract][Full Text] [Related]
19. Palmitoylethanolamide Reverses Paclitaxel-Induced Allodynia in Mice.
Donvito G; Wilkerson JL; Damaj MI; Lichtman AH
J Pharmacol Exp Ther; 2016 Nov; 359(2):310-318. PubMed ID: 27608657
[TBL] [Abstract][Full Text] [Related]
20. Estrogen decline is a risk factor for paclitaxel-induced peripheral neuropathy: Clinical evidence supported by a preclinical study.
Miyamoto T; Hiramoto S; Kanto A; Tsubota M; Fujitani M; Fukuyama H; Hatanaka S; Sekiguchi F; Koizumi Y; Kawabata A
J Pharmacol Sci; 2021 May; 146(1):49-57. PubMed ID: 33858655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
